MDT: 美敦力

MDT新闻

• 02:16 Binance to List Four US Stock Perpetual Contracts: CEG, BAC, IBKR, MDT
• 02:16 币安将上线CEG、BAC、IBKR、MDT四个美股永续合约
• 13:50 DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study
• 13:00 Why ISRG Is Lowering Instrument Costs Despite Strong Profitability
• 20:50 Medtronic (MDT) Stock Dips While Market Gains: Key Facts
• 13:15 Stryker Enters Soft-Tissue Robotics With $400 Million CMR Deal
• 10:56 Is it Apt to Retain Medtronic Stock in Your Portfolio Now?
• 20:27 MiniMed Names Kevin E. Lofton Board Chair, Effective Separation From Medtronic
• 11:58 Jim Cramer: This Health Care Stock Is A ‘Winner’, X-Energy Is ‘Losing Too Much Money’
• 16:35 ISRG Gains Nearly 12% in a Month: Should You Buy, Hold or Sell?
• 13:57 Why Did J&J Stock Fall After Q3 Earnings Despite Raised Guidance?
• 12:06 Medtronic Announces Oversubscribed MiniMed Exchange Offer Results; Accepts 55,032,401 Of Its Shares For All Remaining 252,813,348 MiniMed Shares
• 20:50 Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know
• 12:45 Top 10 Powder Keg Stocks Where Short Sellers Are Sitting on a Fuse
• 12:50 美敦力此前宣布的 MiniMed 股票交换要约认购超额，公司将交换剩余的 252,813,348 股；每接受一股交换要约的美敦力普通股将交换 4.5939 股 MiniMed 普通股
• 12:50 Medtronic’s Previously Announced MiniMed Share Exchange Offer Oversubscribed As Company Moves To Exchange Remaining 252,813,348 Shares; 4.5939 Shares Of MiniMed Common Stock Will Be Exchanged For Each Medtronic Ordinary Share Accepted In The Exchange Offer
• 10:08 BTIG Maintains Buy on Medtronic, Lowers Price Target to $99
• 10:08 BTIG维持对美敦力的买入评级，将目标价下调至99美元
• 02:26 Dividend Champion, Contender, And Challenger Highlights: Week October 11
• 11:35 Jim Cramer Doesn’t Like This Health Care Stock, Sees No Reason To Buy Rambus
• 11:01 华尔街最准确的分析师对3只派发高股息收益率的医疗保健股票发表看法
• 11:01 Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
• 12:57 Barclays Initiates Coverage On Medtronic with Equal-Weight Rating, Announces Price Target of $95
• 14:38 Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?